Skip to content


The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all Asia Pacific countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.

Key features at a glance

multiFiltratePRO acute therapy options
  • Ci-Ca® CVVHD EMiC®2
  • Ci-Ca® CVVHD AV1000S
  • Ci-Ca® postCVVHDF
  • Conventional heparin CRRT
  • Therapeutic Plasma Exchange (TPE)
  • Sepsis therapy
Ergonomic design
  • Large screen enables display of comprehensive information, e.g. therapy information or potential reasons in case of alarms
  • The touch screen monitor has enhanced readability from various angles
  • 4-wheel chassis with 2-stage locking system allows turning on the spot


Easy treatment application
  • Intuitive step-by-step instructions for relevant handling situations
  • To ease handling in the ICU, fluid heaters are fully integrated into the device
  • “Care-Mode” to prevent unnecessary alarms and to save time: temporarily decreased blood flow, stopped balancing system and extended pressure limits during patient care
  • High capacity scales reduce the number of bag changes and thus user interactions
Comprehensive integrated Ci-Ca® anticoagulation
  • Regional Ci-Ca® citrate anticoagulation to minimize the risk of bleeding complications 1,2,3
  • Long effective treatment times allow for efficient fluid removal via low hourly fluid removal rates; this supports hemodynamic stability 4
  • Ci-Ca® avoids downtime, thus the delivered CRRT-dose is in accordance with the prescription 4

multiFiltratePRO Ci-Ca

Integrated Ci-Ca® citrate anticoagulation

Statement on the Ci-Ca® protocol:

[It] enabled an effective treatment of acute renal failure and excellent control on the acid–base status as well on the systemic ionised calcium in combination with negligible clotting issues.2

Ci-Ca protocol included in the software

Supports the user with expert information and features

For routine adjustments of the Ci-Ca therapy, information from the protocol can easily be retrieved on the screen

In case of certain values set outside the standard range, the multiFiltratePRO makes the user aware of potentially risky clinical situations


Screen during Ci-Ca CVVHD application provides key information from the Ci-Ca protocol

Dedicated hardware components for citrate anticoagulation

Clear allocation of functionality

Dedicated pumps for citrate and calcium keep the syringe pump available for heparin application if needed during Ci-Ca therapy. Separate level detectors and drip counters enable timely detection of empty bags, preventing air being transported downstream and enabling a smooth continuation of the treatment. During bag changes (dialysate, substituate, filtrate) the citrate infusion continues for a reliable period of time. This helps to avoid early coagulation of the system


Nurse operating multiFiltratePRO device

Figure 1: Plasma to blood ratio ramp-up

Convenient handling

Large and adjustable monitor


multiFiltratePRO monitor

multiFiltratePRO monitor (side)

The easy-to-read touch screen monitor allows recognition of key information even from a distance. Rotation around the horizontal and vertical axes enables adjustment for different-sized users and to different relative positions of the device and user.

Advanced graphic user interface

The multiFiltratePRO includes a graphic user interface that monitors and displays all relevant set-up and treatment data. The integrated alarm system helps to quickly determine the urgency as well as the root cause of alarms.

The time until the next expected user action is displayed in the status bar at the top right of the screen. In addition, a list of further upcoming user interactions can be retrieved on the screen. Both help to optimize work processes in the ICU.

The “Care Button” switches the multiFiltratePRO into care-mode, by decreasing the blood flow, stopping the balancing system and extending the pressure limits. This will prevent unnecessary alarms when moving the patient or manipulating the catheter.


multiFiltratePRO interface

Easy application of CRRT

KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012. 2:1-138.

2 Morgera S et al., A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Critical Care Medicine 2009. 37:2018-24.

3 Morgera S et al., Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clinical Practice 2004. 97:c131-6.

4 Kalb R et al., Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Therapeutic Apheresis and Dialysis 2013. 17:202-12.

5 Reeves HM et al. The mechanisms of action of plasma exchange. British Journal of Haematology 2014;164(3):342-51.

Sprenger KB et al. Nomograms for the prediction of patient’s plasma volume in plasma exchange therapy from height, weight, and hematocrit. Journal of Clinical Apheresis 1987;3(3):185-90.

Malchesky PS Membrane processes for plasma separation and plasma fractionation: guiding principles for clinical use. Therapeutic Apheresis 2001;5(4):270–282.